| The Predictive Value of FDG PET/CT in the Evaluation of Bone Marrow Involvement in Lymphoma Patients | Buğra KAYA, Kültigin TÜRKMEN, Buğra SAĞLAM, Abdulkerim YILDIZ | 1–8 |
| Diagnostic Value of 1.5 Tesla Multiparametric MRI in Prostate Cancer | Ülkü BEKAR, Şehnaz TEZCAN | 9–15 |
| Long-Term Oncological Outcomes for Patients Treated with Oncoplastic Breast-Conserving Surgery | Gamze KIZILAN, Mehmet Ali GÜLÇELİK, Cihangir ÖZASLAN, Lütfi DOĞAN | 16–24 |
| Evaluation of Effect and Side Effects of Pemetrexed in Patients with Advanced-Stage Lung Adenocarcinoma | Elif ATAĞ, Serkan GÖKÇAY | 25–33 |
| Contribution of Diffusion-Weighted Imaging and Ultrasound Elastography to the Diagnosis of Breast Cancer | Mehmet Ali NAZLI, Kevser Esmeray ÇİFÇİ, Arzu HUSHMAND ARYA | 34–42 |
| Analysis of Demographic and Disease Characteristics of Patients with Chronic Myeloid Leukemia: A Single Centre Retrospective Analysis | Buğra SAĞLAM, Abdülkerim YILDIZ, Ümit Yavuz MALKAN, Murat ALBAYRAK, Senem MARAL, Pınar TIĞLIOĞLU, Merih Reis ARAS, Mesut TIĞLIOĞLU, Fatma YILMAZ | 43–51 |
| Standart Prophylactic Granulocyte Colony Stimulating Factor Usage as a Part of Autologous Stem Cell Transplantati̇ on Procedure | Zübeyde Nur ÖZKURT, Münci YAĞCI, Özlem GÜZEL TUNÇCAN, Lale AYDIN KAYNAR, Zeynep Arzu YEĞİN, Ferda CAN | 52–57 |
| Value of ADC Thresholds to Diagnose Head and Neck Lesions: Can ADC Values Replace Biopsy? | Muhteşem AĞILDERE, Şehnaz TEZCAN, Funda ULU ÖZTÜRK, Fuldem DÖNMEZ | 58–67 |
| Palbociclib Associated Deep Vein Thrombosis: A Case Report | Özlem SÖNMEZ, Elif ŞENOCAK TAŞCI | 68–71 |
| Hodgkin Lymphoma Identified After Non-Hodgkin Lymphoma: Two Case Reports | Fevzi ALTUNTAŞ, Ersin BOZAN, Mehmet Sinan DAL, Tuğçe Nur YİĞENOĞLU, Merih KIZIL ÇAKAR | 72–76 |